Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Jul 2017
At a glance
- Drugs Ipilimumab (Primary)
- Indications Brain metastases; Malignant melanoma
- Focus Therapeutic Use
- 15 Dec 2016 Status changed from recruiting to active, no longer recruiting.
- 29 May 2015 Trial design presented at 51st Annual Meeting of the American Society of Clinical Oncology.
- 16 Oct 2014 Status changed from not yet recruiting to recruiting according to ClinicalTrials.gov record.